Regeneron Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript
Yes. So my name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to welcome everyone to the 2019 London Healthcare Conference. Our next company is Regeneron Pharmaceuticals. We have their CFO, Bob Landry, to give us an overview initially and then followed by a Q&A that I'll moderate.
Good. So thanks. Hello, everybody. Good afternoon. Good morning and good evening, if you're on our webcast. Happy to be invited here by Jefferies. So we're going to kind of do a dual split here. I'll throw some slides up at a high level, talk through it and then we'll move over and we'll do probably 15, 20 minutes of Q&A, depending upon how quick we can get through everything. We do have a corporate presentation that is on our website, okay? So you can access that at the conclusion of this meeting. And again, comments expressed here today will include forward-looking statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |